The PD-1 receptor is expressed, among the others, on the surface of T cells, and its binding to PD-L1 ligands on the surface of tumor cells (and other cells in the tumor microenvironment) negatively regulates T cells functions and allows tumor evasion of immune surveillance (138). This evidence concerns the gene CD274 and neoplasm.